Abstract
Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Patients with Multiple Myeloma Treated with Continuous Lenalidomide Maintenance Therapy: A Clinical and Correlative Phase 2 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have